p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer

Clinical Cancer Research

Volumn 4, Issue 7, 1998, Pages 1609-1618

  Brambilla, Elisabeth ^a,b   Gazzeri, Sylvie ^a   Lantuejoul, Sylvie ^a   Coll, J Luc ^a   Moro, Denis ^a   Negoescu, Adrien ^a   Brambilla, Christian ^a  

^a HÔPITAL MICHALLON   (France)

^b Laboratoire de Pathologie Cellulaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MUTANT PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; BRONCHUS INJURY; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CLINICAL ARTICLE; DISEASE ASSOCIATION; DOWN REGULATION; DYSPLASIA; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; PRIORITY JOURNAL;

BCL-2-ASSOCIATED X PROTEIN; BRONCHIAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENES, P53; HUMANS; IMMUNOPHENOTYPING; LUNG NEOPLASMS; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031800307     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Shopland, D. R., Eyre, H. J., and Pechacek, T. F. Smoking attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States. J. Natl. Cancer Inst. (Bethesda), 83: 1142-1148, 1991.
2. Takahashi, T., Nau, M., Chiba, L., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, W., Pass, H., Gazdar, A. F., and Minna, J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
3. Iggo, R., Gatter, K., Bartek, J., Lane, D., and Harris, A. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335: 675-679, 1990.
4. Brambilla, E., Gazzeri, S., Moro, D., Caron de Fromentel, C., Gouyer, V., Jacrot, M., and Brambilla, C. Immunohistochemical study of p53 in human lung carcinomas. Am. J. Pathol., 143: 199-210, 1993.
5. Mitsudomi, T., Oyama, T., Kusan, T., Osaki, T., Nakanishi, R., and Shirakusa, T. Mutations of the p53 gene as a predictor of poor prognosis in patients with non small cell lung. J. Natl. Cancer Inst. (Bethesda), 85: 2018-2023, 1993.
6. Gazzeri, S., Brambilla, E., Caron de Fromentel, C., Gouyer, V., Moro, D., Perron, P., Berger, F., and Brambilla, C. p53 genetic abnormalities and myc activation in human lung carcinoma. Int. J. Cancer, 58: 24-32, 1994.
7. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
8. Lee, J. S., Yoon, A., Kalapurakal, S. L., Ro, J. Y., Lee, J. J., Tu, N., Hittelman, W. N., and Haig, W. K. Expression of p53 oncoprotein in non small cell lung cancer: a favorable prognostic factor. J. Clin. Oncol., 13: 1893-1903, 1995.
9. Harbour, J. W., Lai, S. L., Whang-Peng, J., Gazdar, A., Minna, J. D., and Kaye, F. J. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science (Washington DC), 241: 353-357, 1988.
10. Yokota, J., Akiyama, T., Fung, Y. J., Benedict, W. F., Namba, Y., Hanaoka, M., Wada, M., Terasaki, T., Shimosato, Y., and Sugimura, T. Altered expression of the retinoblastoma (Rb) gene in small cell carcinoma of the lung. Oncogene, 3: 471-475, 1988.
11. Hensel, C. H., Hsieh, C. L., Gazdar, A. F., Johnson, B. E., Sakaguchi, A. Y., Naylor, S. L., Lee, W. A., and Lee, E. Y. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res., 50: 1067-1072, 1990.
12. Reissmann, P. T., Koga, H., Takahashi, R., Figlin, R. A., Holmes, E. C., Piantadosi, S., Cordon-Cardo, C., and Slamon D. J. Inactivation of the retinoblastoma susceptibility gene in non small cell lung cancer. Oncogene, 8: 1913-1919, 1993.
13. Gouyer, V., Gazzeri, S., Brambilla, E., Bolon, I., Moro, D., Perron, P., Benabid, A. L., and Brambilla, C. Loss of heterozygosity at the Rb locus correlates with loss of Rb protein in primary malignant neuroendocrine lung carcinomas. Int. J. Cancer, 58: 818-824, 1994.
14. Shimizu, E., Coxon, A., Otterson, G. A., Steinberg, S. M., Kratzke, R. A., Kim, Y. M., Fedorko, J., Oie, H., Johnson, B. E., and Mulshine, J. L. Rb protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene, 9: 2441-2448, 1994.
15. Sachse, R., Murakami, Y., Shiraishi, M., Hayashi, K., and Sekiya, T. DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung. Oncogene, 9: 39-47, 1994.
16. 4INK4 protein in restricted to the subset of lung cancer lines that retains wild type Rb. Oncogene, 9: 3375-3378, 1994.
17. INK4B/MTS2 and p18 genes in primary and metastatic lung cancer. Cancer Res., 55: 1448-1451, 1995.
18. INK4 expression in primary lung cancers and cell lines. Cancer Res., 55: 505-509, 1995.
19. INK4 expression in resected non small cell lung tumors. Cancer Res., 56: 3415-3420, 1996.
20. Sakaguchi, M., Fujii, Y., Hirabayashi, H., Yoon, N. E., Komoto, Y., One, T., Kusafuka, T., Okada, A., and Matsuda, H. Inversely correlated expression of p16 and Rb protein in non small cell lung cancers: an immunohistochemical study. Int. J. Cancer, 65: 442-445, 1996.
21. INK4B and p18 genes in primary non small cell lung cancers. Int. J. Cancer, 65: 734-739, 1996.
22. 2 protein in non-small-cell lung carcinoma. N. Engl. J. Med., 329: 690-694, 1993.
23. Fontanini, G., Vignati, S., Bigini, D., Mussi, A., Lucchi, M., Angeletti, C. A., Basalo, F., and Bevilacqua, G. Bcl2 protein: a prognostic factor inversely correlated to p53 in non small cell lung cancer. Br. J. Cancer, 71: 1003-1007, 1995.
24. Brambilla, E., Negoescu, A., Gazzeri, S., Lantuejoul, S., Moro, D., Brambilla, C., and Coll, J. L. Apoptosis related factors p53, Bcl2 and Bax in neuroendocrine lung tumors. Am. J. Pathol., 149: 1941-1952, 1996.
25. Ono, J., Auer, G., Caspersson, T., Nasiell, M., Saito, T., Konaka, C., Kato, H., and Hayata, Y. Reversibility of 20 methylcholanthrene induced bronchial cell atypia in dogs. Cancer (Phila.), 54: 1030-1037, 1984.
26. Becci, P. J., McDowel, E. M., and Trump, B. F. The respiratory epithelium IV. Histogenesis of epidermoid metaplasia and carcinoma in situ in the hamster. J. Natl. Cancer Inst. (Bethesda), 61: 577-586, 1978.
27. Auerbach, O., Hammond, E. C., and Garfinkel, I. Changes in bronchial epithelium in relation to cigarette smoking 1955-1960 vs. 1970-1977. N. Engl. J. Med., 300: 381-386, 1979.
28. Peters, E. J., Morice, M., Benner, S. E., Lippman, S., Lukeman, J., Lee, J. S., Ro, J. Y., and Hong, W. K. Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest, 103: 1429-1432, 1993.
29. Kishimoto, Y., Sugio, K., Hung, J. Y., Virmani, A., McIntire, D. D., Minna, J. P., and Gazdar, A. F. Allele specific loss in chromosome 9p loci in preneoplastic lesions accompanying non small cell lung cancers. J. Natl. Cancer Inst. (Bethesda), 87: 1224-1229, 1995.
30. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D. D., Minna, J. D., and Gazdar, A. F. Allele specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc., 275: 558-563, 1995.
31. Auer, G., Ono, J., Nasiell, M., Caspersson, T., Kato, H., Konaka, C., and Hayata, Y. Reversibility of bronchial cell atypia. Cancer Res., 42: 4241-4247, 1982.
32. Band, P., Feldstein, M., and Saccomanno, G. Reversibility of bronchial marked atypia: implication for chemoprevention. Cancer Detect. Treat., 9: 157-160, 1986.
33. Hammond, W. G., Teplitz, R. L., and Benfield, J. R. Variable regression of experimental bronchial preneoplasia during carcinogenesis. J. Thorac. Cardiovasc. Surg., 101: 800-806, 1991.
34. Sawyer, R. W., Hammond, W. G., Teplitz, R. L., and Benfield, J. R. Regression of bronchial epithelial cancer in hamsters. Ann. Thorac. Surg., 56: 74-78, 1993.
35. Vogelstein, B., and Kanzler, K. W. The multistep nature of cancer. Trends Genet., 9: 138-141, 1993.
36. Sozzi, G., Miozzo, M., Donghi, R., Pilotti, S., Cariani, C. T., Pastorino, U., Della-Porta, G., and Pierotti, M. A. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res., 52: 6079-6082, 1992.
37. Sundaresan, V., Ganly, P., Hasleton, P., Rudd, R., Sinha, G., Bluhen, N. H., and Rabbitts, P. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene, 7: 1989-1997, 1992.
38. Klein, N., Vignaud, J. M., Sadmi, M., Plenat, F., Borelli, J., Dyprez, A., Martinet, Y., and Martinet, N. Squamous metaplasia expression of proto-oncogenes and p53 in lung cancer patients. Lab. Invest., 68: 26-32, 1993.
39. Bennett, W. P., Colby, T. V., Travis, W. D., Borkowski, A., Jones, R. T., Lane, D. P., Metcalf, R. A., Samet, F. M., Takeshima, Y., and Gu, J. R. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res., 53: 4817-4822, 1993.
40. Nuorva, K., Soini, Y., Kamel, D., Autio-Harmainen, H., Risteli, L., and Risteli, J. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am. J. Pathol., 142: 725-732, 1993.
41. Walker, C., Robertson, L. J., Myskow, N. W., Pendleton, N., and Dixon, G. R. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br. J. Cancer, 70: 297-303, 1994.
42. Fontanini, G., Vignati, S., Bigini, D., Merlo, G. R., Ribecchini, A., Angeletti, C. A., Basolo, F., Pingitore, R., and Bevilacqua, G. Human non small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J. Pathol., 174: 23-31, 1994.
43. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
44. El-Deiry, W. S., T. Tokino, T., Velculescu, V. E., Levy, D. B., R. Parsons, R., Trent, J. M., Lin, D., and Mercer, W. E. Wafl, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
45. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
46. 2 and bax in gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1994.
47. WHO. Histological typing of lung tumours. In: International Histological Classification of Tumours, Ed. 2. Geneva: WHO, 1981.
48. Brambilla, E., Moro, D., Veale, D., Brichon, P. Y., Stoebner, P., Paramelle, B., and Brambilla, C. Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognosis significance. Hum. Pathol., 23: 993-1003, 1992.
49. Travis, W. D., Linnoila, R. I., Tsokos, M. G., Hitchcock, C. L., Cutler, G. B., Nieman, L., Chrousos, G., Pass, H., and Doppan, J. Neuroendocrine tumors of the lung with proposed criteria for large cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am. J. Surg. Pathol., 15: 529-553, 1991.
50. Quinlan, D. C., Davidson, A. G., Summers, C. L., Warden, H. E., and Doshi, H. M. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res., 52: 4828-4831, 1992.
51. McLaren, R., Kuzu, I., Dunnill, M., Harris, A., Lane, D., and Gatter, K. C. The relationship of p53 immunostaining to survival in carcinoma of the lung. Br. J. Cancer, 66: 735-738, 1992.
52. Caamano, J., Ruggeri, B., Momiki, S., Sickler, A., Shang, S. Y., and Klein-Szanto, A. J. P. Detection of p53 in primary lung tumors and non small cell lung carcinoma cell lines. Am. J. Pathol., 139: 839-845, 1991.
53. Dalquen, P., Sauter, G., Torhorst, J., Schultheiss, E., Jordan, P., Lehmann, S., Soler, M., Stulz, P., Minhatsch, M. J., and Gudat, F. Nuclear p53 overexpression is an independent prognostic parameter in node negative non small cell lung carcinoma. J. Pathol., 178: 53-58, 1996.
54. Bodner, S. M., Minna, J. D., Jensen, S. M., D'Amico, D., Carbone, D., Mitsudomi, T., Fedorko, J., Buchhaggen, D. L., Nau, M. M., and Gazdar, A. F. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene, 7: 743-749, 1992.
55. Winford-Thomas, D. p53 in tumour pathology: can we trust immunochemistry? J. Pathol., 166: 329-330, 1992.
56. Hainaut, P., Butcher, S., and Milner, J. Temperature sensitivity for conformation is an intrinsic property of wild-type p53. Br. J. Cancer, 71: 227-231, 1995.
57. Boers, J. E., Ten-Velde, G. P. M., and Thunnissen, F. B. J. M. p53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma. Am. J. Respir. Crit. Care Med., 153: 411-416, 1996.
58. Sozzi, G., Miozzo, M., Pastorino, U., Pilotti, S., Donghi, R., Giarola, M., DeGregorio, L., Marenti, G., Radice, F., and Minoletti, F. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res., 35: 135-140, 1995.
59. Chung, G. T. Y., Sundaresan, V., Hasleton, P., Rudd, R., Taylor, R., and Rabbitts, P. Sequential molecular genetic changes in lung cancer development. Oncogene, 11: 2591-2598, 1995.
60. Chung, G. T. Y., Sundaresan, V., Hasleton, P., Rudd, R. Taylor, R., and Rabbitts, P. Clonal evolution of lung tumors. Cancer Res., 56: 1609-1614, 1996.
61. Bedi, G. C., Westra, W., Gabrielson, E., Koch, W., and Sidransky, D. Multiple head and neck tumors. Evidence for a common clonal origin. Cancer Res., 56: 2484-2487, 1996.
62. Walker, C., Robertson, L., Myskow, M., and Dixon, G. Expression of the Bcl2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Br. J. Cancer, 72: 164-169, 1995.
63. Di-Giuseppe, J. A., Redston, M. S., Yeo, C. J., Kern, E. S., and Hruban, R. H. p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am. J. Pathol., 147: 884-888, 1995.
64. cip1 in muscle and other terminally differentiating cells. Science (Washington DC), 267: 1024-1027, 1995.
65. Waf1/cip1 in non neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity. J. Pathol., 180: 122-128, 1996.
66. Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar A. F., Piatyszek, M., and Shay, J. W. Telomerase activity in small cell and non small cell lung cancers. J. Natl. Cancer Inst. (Bethesda), 87: 895-902, 1995.
67. Bolon, I., Brambilla, E., Vandenbunder, B., Robert, C., Lantuejoul, S., and Brambilla, C. Changes in the expression of matrix proteases and of the transcription factor c-ets-1 during progression of precancerous bronchial lesions. Lab. Invest., 75: 1-13, 1996.